MacroGenics reported $-27460000 in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
AbbVie USD 9.34B 1.36B Mar/2025
Amgen USD 6.17B 624M Jun/2025
AstraZeneca USD 11.98B 637M Jun/2025
Biogen USD 2.04B 238.8M Jun/2025
Bristol-Myers Squibb USD 8.9B 714M Jun/2025
Daiichi Sankyo JPY 382.25B 42.1B Jun/2025
Eli Lilly USD 13.11B 2.61B Jun/2025
Genmab DKK 868M 195M Jun/2025
Geron 47.85M 9.45M Jun/2025
Gilead Sciences USD 5.58B 453M Jun/2025
J&J USD 14.6B 816M Mar/2025
MacroGenics USD -27460000 41.32M Jun/2025
Merck USD 12.99B 224M Jun/2025
Pfizer USD 10.88B 248M Jun/2025
Regeneron Pharmaceuticals USD 3.15B 581M Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024
Xencor 43.61M 10.88M Jun/2025